House Roll Call

H.R.586

Roll 89 • Congress 119, Session 1 • Apr 7, 2025 6:54 PM • Result: Passed

← Back to roll call listView bill pageClerk recordAPI source

BillH.R.586 — Vietnam Veterans Liver Fluke Cancer Study Act
Vote questionOn Motion to Suspend the Rules and Pass, as Amended
Vote type2/3 Yea-And-Nay
ResultPassed
TotalsYea 411 / Nay 0 / Present 0 / Not Voting 22
PartyYeaNayPresentNot Voting
R2070013
D204009
I0000

Research Brief

On Motion to Suspend the Rules and Pass, as Amended

Bill Analysis

Bill Summary: HR 586 - Vietnam Veterans Liver Fluke Cancer Study Act

The Vietnam Veterans Liver Fluke Cancer Study Act (HR 586) aims to address the health impacts of liver fluke infections on Vietnam veterans. Specifically, the bill mandates the Department of Veterans Affairs (VA) to conduct a comprehensive study on the correlation between liver fluke infections and the incidence of bile duct cancer among veterans who served in Vietnam, where exposure to the liver fluke parasite is prevalent due to environmental factors.

Key Provisions:

  • The bill directs the VA to undertake a thorough epidemiological study to assess the potential link between liver fluke infections and the increased risk of bile duct cancer in Vietnam veterans.
  • It requires the VA to report its findings to Congress within a specified timeframe, ensuring transparency and accountability in the research process.

Funding and Authorities:

  • The bill authorizes necessary appropriations to fund the study, although specific funding amounts are not detailed within the text. The VA is tasked with utilizing existing resources to conduct the research effectively.

Programs and Agencies Affected:

  • The primary agency involved is the Department of Veterans Affairs, which will oversee the study and analysis.
  • The findings may influence health care programs and policies related to veteran health, particularly concerning cancer treatment and preventive measures.

Beneficiaries and Regulatory Impact:

  • The primary beneficiaries are Vietnam veterans who may be at risk for liver fluke infections and subsequent bile duct cancer. The study aims to provide critical data that could lead to improved healthcare services and support for affected veterans.
  • The bill may also have implications for public health policy and veterans’ health regulations, particularly in terms of recognizing and addressing service-related health issues.

Key Timelines:

  • Following its introduction, HR 586 was received in the Senate, read twice, and referred to the Committee on Veterans’ Affairs, where it awaits further consideration and potential advancement through the legislative process. The timeline for the completion of the study and reporting back to Congress is yet to be established.

Yea (411)

K
Ken Calvert

CA • R • Yea

J
Jason Crow

CO • D • Yea

L
Lloyd Doggett

TX • D • Yea

S
Scott Franklin

FL • R • Yea

J
John Garamendi

CA • D • Yea

M
Mark Green

TN • R • Yea

J
John Mannion

NY • D • Yea

L
Lucy McBath

GA • D • Yea

L
Lisa McClain

MI • R • Yea

J
John Rutherford

FL • R • Yea

D
David Schweikert

AZ • R • Yea

P
Pete Sessions

TX • R • Yea

N
Nydia Velázquez

NY • D • Yea

D
Debbie Wasserman Schultz

FL • D • Yea

Not Voting (22)

G
Gerald Connolly

VA • D • Not Voting

E
Eric Swalwell

CA • D • Not Voting

R
Rashida Tlaib

MI • D • Not Voting